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Summary Rabbits immunized via chronically isolated ileal loops with aflatoxin B, (AFB) conjugated to
porcine thyroglobulin (TG) mixed with the mucosal adjuvant cholera toxin (CT) produced ver\' small mucosal
antibody responses to AFB. Strong mucosal and systemic antibody responses to CT and TG were generated by
this immunization protocol, suggesting that the observed unresponsiveness was specific to AFB. Parenteral
immunization with AFB-TG produced strong serum IgG anti-AFB responses, indicating that the conjugate
preparation was immunogenic and that the rabbits possess the requisite systemic B and T cell repertoires to
recognize and respond to AFB. This mucosal unresponsiveness was distinct from oral tolerance, as animals
immunized mucosally with AFB-TG mixed with CT produced vigorous serum IgG anti-AFB responses upon
subsequent parenteral immunization with AFB-TG. //; vitt-o mitogen stimulation of lymphocytes isolated
from Peyer"s patches and mesenteric lymph nodes of unimmunized rabbits revealed the presence of AFB-
specific B cells at levels comparable with those found in the spleen. These observations indicate that
unresponsiveness to AFB is hapten-specific, restricted to the mucosa. and refractop, to the adjuvancy of CT.
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Introduction
Moolten et al. performed the first studies aimed at elicit-
ing mucosal antibodies (Ab) to block carcinogen absorp-
tion.'-^ Mice immunized parenterally and orally with an
analogue of the polycyclic aromatic hydrocarbon (PAH)
7,12-dimethylbenzanthracene covalently coupled to BSA
generated intestinal immunoglobulin capable of binding
the parent compound tn vitto. Additionally, the faecal Ig
fraction from immunized animals bound more radiolabel
than that of control animals following oral challenge
with [-̂ H]-PAH,' suggesting a mechanism of Ab-mediated
carcinogen clearance. In more recent studies, mucosal
immunization of rabbits via chronically isolated ileal
loops with a 2-acetylaminofluorene (AAF) derivative
conjugated to carrier proteins and mixed with the mu-
cosal adjuvant cholera toxin (CT) generated a vigorous
intestinal secretory IgA (S-IgA) anti-AAF response.-^-^
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Furthermore, passive immunization of isolated ilea! seg-
ments with S-IgA anti-AAF reduced transmucosal absorp-
tion of radiolabelled AAF from the lumen by 58%."̂
Cholera toxin is an enterotoxin produced by librio
cholerae which, unlike most protein Ag. is a potent mu-
cosal immunogen."^ Cholera toxin is also a mucosal ad-
juvant when administered orally with proteins, viruses,
and hapten-carrier protein conjugates.^""* It exerts a num-
ber of immunomodulator\' effects, including: (t) up-
regulation of Ag presentation and lL-1 secretion by
macrophages:'°" (ii) promotion of B cell isotype switch-
ing from IgM to IgG and IgA;'- '-̂  and (iii) increased
priming of T cells and induction ofa Th2 type cytokine
profile, concomitant with inhibition of Thl type re-
sponses in the gut.'"*""'
Although CT can block the induction of mucosal and
systemic tolerance to co-administered Ag." ^ its ability to
abrogate an established mucosal or systemic tolerance
remains unresolved. Oral priming with keyhole limpet
haemocyanin (KLH) followed by an oral boost with a
mixture of KLH and CT resulted in a markedly dimin-
ished mucosal Ab response to KLH relative to that seen
when both priming and boosting doses contained CT.^
Similar results were obtained using ovalbumin (OVA)
along with the heat-labile enterotoxin of E. colt (LT).'"^
These data suggest that bacterial enterotoxins may not be
effective mucosal adjuvants for Ag to which tolerance has
already been established.
Aflatoxin B, (AFB), a secondary metabolite produced
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by several moulds, most notably Aspergillus flavus, is an
ubiquitous contaminant of many food crops. In prelimi-
nary studies we observed an unexpectedly small intestinal
S-IgA anti-AFB response following mucosal immuniza-
tion of rabbits via isolated ileal loops with AFB-carrier
protein conjugates mixed with CT. These results contrast
with those of our previous studies in which similar conju-
gates prepared using AAF as the hapten generated strong
intestinal S-lgA responses to the AAF determinant when
used in a similar immunization protocol.-^"^ '^
The goals of the present study were to determine if
mucosal unresponsiveness to AFB: (i) could be broken by
CT; (ii) was restricted to the mucosal arm ofthe immune
system; and (iii) was specific to the AFB determinant or
indicative of a more generalized mucosal immunosup-
pression.
Materials and methods
Animals, surgery and immunization
Specific pathogen-free female New Zealand White rabbits (2.6-
3.0 kg. Hazleton Research Products, Denver. PA. USA) were
housed tor at least 1 week prior to surgcr\'; fed 125g/day of
Purina Certified High Fiber Rabbit Diet HF5.'̂ 26 (Purina Mills.
St Louis. MO. USA) and provided with water ad libitum. All
animal use protocols were approved by the University of
Connecticut's Institutional Animal Care and Use Committee.
Chronically isolated ileal loop surger\ (Thm-Vella) was per-
formed essential!) as described by Keren ei al''' with minor
modifications. Animals were fasted for 24 h prior to surgery and
anaesthetized with ketamine (lOOmg/kg) and xylazine (lOmg/
kg). A midlinc incision was made to expose the terminal ileum.
and a 15 cm section containing one Pcyer"s patch (PP) was ex-
cised, leaving the surrounding vaseulature intact. The mesentery
was then incised to allow movement ofthe excised segment and
intestinal continuity was restored by end-to-end anastomosis.
Each end of the excised segment was surgically attached to a
length of plastic silastic tubing, which was anchored to the body
wall near the site ofthe midline incision. The tubing was tun-
nelled subeutaneously and exteriorized near the scapulae. The
incision was then closed in two layers and the animals were fitted
with plastic collars to prevent damage to the tubes. Heal secre-
tions were collected daily by tlu^hing the loop with 10 cm' of air
from a syringe and collecting the fluid expelled from the opposite
tube. The loop was then flushed with lOcm^of sterile saline, and
finally with 10 cm-̂  of air, leaving it empty.^"Collected secretions
were centrifuged for 5 min at 200 x^ at room temperature to
remove mueus, and supematants were collected and stored at
- 2 0 X until assay.
Mucosal immunizations were administered following flushing
of the ileal loops, generally within 2 days of surgery. Priming
doses consisted of 100 jig of AFB-TG or unconjugated TG. with
or without lOO^g of CT (Azide-free holotoxin. List Biological
Laboratories, Campbell. CA. USA), in a total volume of 4 mL of
PBS. followed by three identical weekly boosts. This dose of CT
(expressed as a milligram of CT per kg bodyweight basis) is about
one-tenth of the dose customarily administered to mice. Intra-
muscular priming immunizations consisted of 100 ^g of
AFB-TG or unconjugated TG in PBS emulsified with an equal
volume of CFA. A total volume of 1 mL was injected into four
locations over the hips followed by a similar dose in IFA 4 weeks
later. Animals were bled via the auricular artery prior to immu-
nization and weekly thereafter. Blood was stored overnight at
4''C to allow clotting, centrifuged (400 x e, 10 min, room temper-
ature), and the serum fraction aspirated and stored at -20°C
until assay. The immunization schedule is shown in Table 1.
Synthesis of AEB-O-carboxymethyloxime
In order to couple AFB to carrier proteins, the parent molecule
was first derivatized to the O-carboxymethyl oxime using a mod-
ification ofthe methods of Chu et al.-^ -- and Langone (7 a/.-'
Briefly. 92 mg of AFB (0.29 mmol, Sigma Chemical Co., St
Louis. MO, USA) was dissolved in 25 mL of a pyridine-
methanol-water (1:4:1) solvent system. To this solution
121.8 mg of carboxymethoxylaminc hemihydrochloride was
added (0.55 mmol. Aldrich Chemical Co.. Milwaukee, Wl.
USA), and the mixture was heated to 80°C for 3 h with stirring in
a round bottom flask protected from light. The reaction was
monitored by thin layer chromatography (TLC) using a glacial
acetic acid-acetone-chloroform solvent system (5 :45:50) in
which AFB travelled with an R,- value of 0.65. while the oxime
travelled at an R, of 0.53. After cooling, the solvent was removed
using a gentle stream of dry nitrogen gas overnight. The solid was
then taken-up in the TLC solvent system and applied to an
Adsorbosil Plus silica gel column previously equilibrated with the
same solvent system (10 m. 0.8 x 60 cm, Alltech Associates,
Deerfield. IL. USA). The two main fractions which eluted imme-
diately after the unreaeted AFB were combined and the solvent
was removed by rotoevaporation. The solid was taken-up in
Table 1 Immunization schedule


























Days 7, 14, 21; 25,55
Day 30
Day 30
Intra-loop (IL) immunizations consisted ofa priming dose of lOO^geach of conjugate or Thyroglobulin (TG) with 100 ng of cholera
toxin (CT), as indicated, via chronically isolated ileal loops, in PBS, followed by three identical booster doses. Intramuscular immuniza-
tions consisted ofa priming dose of 100 p̂ g of aflatoxin B|-TCi or TG emulsified in CFA and a booster dose 1 month later in IFA. All
animals were given a priming dose on day 0. Group V animals were immunized IL with AFB-TG mixed with CT, and subsequently twice
i.m. with AFB-TG in CFA/IFA as described in materials and methods.
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water (pH 10). then twice extracted with an equal volume of ethyl
acetate. The aqueous layer was then acidified to pH 2 with
concentrated HCI. and the precipitate was vacuum hltcred to
give about 57% yield of pure AFB-oxime. The identity of the
purified product was confirmed by [^H]-NMR. infrared spectros-
copy, mass spectroscopy and HPLC, with results in agreement
with Chu el al.^-
AEB conjugates
To produce the conjugates, 20 mg of AFB-O-carboxymethyl
oxime was dissolved in 2 mL of dimcthyiformamide (DMF).
Twenty milligrams of l-ethyI-3-(3-dimethylaminopropyI) carbo-
diimide (EDAC) dissolved in 2 mL of 0.5 mol/L 2-{N-
morpholino)ethanesulfonic acid (MES) butfer. pH 4.75, was
added to the AFB-0-carboxymethyl oxime dropwise with stir-
ring. The solution was allowed to stand at room temperature for
15 min with occasional vortcxing. This solution was then added
dropwise with stirring to a solution of 10 mg of TG in 6 mL of
0.5 mol/L cyclohexylaminoethane sulfonic acid (CHES) buffer.
pH 9.5, in a foil wrapped beaker. This solution was co\ered and
stirred gently for 4 h at room temperature. The conjugate solu-
tion was then dialyzed agamst two changes of 2 L of 50 mmol/L
PBS(pH 7.3. 10% DMF) at 4'C and four changes of 2 L of PBS.
Removal of unconjugated AFB from the conjugate preparation
was determined spectrophotometrically by the disappearance of
the characteristic peaks at 263 and 363 nm in the dialysatc. The
protein concentration of the resulting conjugate solution was
determined by Bradford assay--* using a BSA standard curve. The
concentration of conjugated AFB was estimated based on the
molar absorptivity of unconjugated AFB at 363 nm (20 950). b>
substitution into Beer's absorbance equation. Only conjugates
with molar ratios exceeding 10 AFB moieties per 100 kDa of
carrier protein were used. The conjugate preparation was then
aliquotted and stored at - 20°C until use.
ELISA
Microtitre plates (Immulon 4. Dynatech. Chantilly. VA. USA)
were coated with AFB-BSA conjugate. TG. BSA {Sigma. St
Louis., MO, USA), or CT, at lO^ig/mL in carbonate butfer
(0.05 mol/L, pH 9.6). Plates were incubated overnight at room
temperature and stored at 4°C until use.
Serum or intestinal secretions diluted in wash buffer
(0.05 mol/L Tris-buffered saline, pH 7.5. containing 0.1% Tween
20 and 0.1% BSA) was added to plates and incubated at room
temperature for 1 h. Plates were washed eight times with wash
buffer using a microplate washer (Biotck EL 311, Winooski. VT,
USA) followed by the addition of affinity purified isotype specific
secondary Ab (biotinylated goat anti-rabbit IgA or alkaline
phosphatase-labelled goat anti-rabbit IgG) diluted in wash buffer
and incubated overnight at 4''C. Following another wash,
streptavidin-alkaline phosphatase diluted in wash buffer was
added to plates eontaining biotinylated secondary Ab after wash-
ing. Plates were developed using the Immunoselect ELISA Am-
plification System (Gibco BRL, Gaithersburg, MD. USA) to
maximize the sensitivity of the assay. The substrate was incu-
bated at room temperature for 20 min prior to addition of ampli-
fier solution, and the absorbance was measured at 490 nm 5, 10
and 20 min after addition of the amplifier solution. All assays
were performed in duplicate and positive and negative controls
were included on all plates. The positive control consisted of
pooled scrum or intestinal secretions as appropriate from re-
sponding animals used at a dilution that yielded an approximate
net OD of 1.0: the negative control consisted of pooled serum or
intestinal secretions from unimmunized animals assayed at the
same dilution as the serum or secretions in question. The net OD
was calculated as the average 20 mm OD of duplicate wells
containing the relevant Ag minus the average OD of duplicate
BSA-coatcd wells. To compensate for between-plate variability,
individual plates were normalized to the mean ofthe appropriate
positive control. Titre was opcrationalK defined as the highest
log-, dilution giving a net OD greater than twice the background
OD. The Ag specificity of ELISA responses was verified by com-
petition with excess Ag in the liquid phase (data not shown).
Preparation of cell suspensions
Unimmunized animals were killed b\ sodium pentobarbital
overdose and a midline abdominal incision was made to cxf)ose
the small bowel. Spleens (SP) and mesenteric lymph nodes
(MLN) were located. asepticalK removed, and placed in indi\ id-
ual dishes of mcomplete medium (Iscovcs Modified Dulbecco's
Medium containing 2 mmol/L-glutammc, 50^mol/L of 2-ME
and 50^g/mL of gentamycin). Pcyer"s patches were removed,
trimmed with small scissors, and placed in incomplete medium.
After removal of PP. about 20 cm of small intestine was placed in
Ca-* and Mg^*-free HBSS containing antibiotic-antimycotic
(100 U/mL pcnicillm. lOOpg/mL streplom\cin. 0.025 jjg/mL
amphotericin B, Gibco BRL). Spleen. PP and MLN were trans-
ferred to sterile incomplete medium. Splenic lymphocytes were
obtained b\ injecting incomplete medium mto the organ with a
22 gauge needle. Mesenteric lymph nodes and PP were minced
with small scissors, pressed between frosted glass slides to disso-
ciate cell clumps, filtered through a fine mesh screen and allowed
to settle for 5 mm to remo\c debris. Cells were washed twice by
centrifugation (200 • ,L,'. 10 min, room temperature) and resus-
pended in incomplete medium. Cells suspended in complete
medium (incomplete medium with antibiotic-antimycotic and
10% FCS (Gibco BRL. Gaithersburg. MD. USA) added) were
underlaid with 40 and 6i)% Percoll and centrifuged at 1900 x t^
for 13 min. Lymphocytes were collected from the 40:60 inter-
face, washed three times as above, and resuspended in complete
medium. Cells were then counted with a haemacytometer. Cell
viability was consistently greater than 95'!'(i b\' tr>pan blue dye
exclusion.
Lamina propria (LP) lymphoc\tcs were obtained b\ a modifi-
cation ofthe method of Da\ies and Parrott -̂  Following removal
of PP. about 20 cm ofthe small intestine was flushed with incom-
plete medium and transferred to a dish containing HBSS wiih
antibiotic-anlimycotic and 5 mmol/L EDTA. Tissue was sliced
longitudinally, cut into 0.5 cm segments and genth stirred at
room temperature. Medium was drawn off and replaced as il
clouded with shed epithelial cells. Tissue segments were then
incubated with shaking in HBSS containing 20 U/mL of collage-
nase (CLS 2, Worthington Biochemical. Freehold. NJ. USA) and
5% FCS for 90 mm at room temperature. The supernatant was
then drawn off and centrituged (200 x tr. 10 mm. room tempera-
ture), and the cell pellet was resuspended in incomplete medium.
Cells were washed, fractionated b\ Percol! gradient separation,
and assayed lor viability as described above.
Mitogen stimulation
Lymphocytes (2x10*' cells/mL) in complete medium were cul-
tured with 50Mg/mL of LPS from S. enternidis (3126-25. Difco.
Detroit. Ml. USA) and 2.5 ng/mL of PWM (Sigma) for 4 days
(37.5''C. 5% CO; in humidified air). This protocol was found to
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induce maximal proliferation measured by [^H]-thymidine incor-
poration and cell counting (data not shown). Cells were fed on
days 2 and 4 by removing half of the medium and replacing it
with an equal volume of complete medium. Control cells were
cultured under identical conditions without mitogen. On day 4.
eells were harvested for ELISPOT analysis.
Enzyme-linked immunosorbent spot assay (ELISPOT)
The ELISPOT technique was adapted from Czerkinski-^ with
modifications. Sterile 96-well nitrocellulose bottom plates
(MAHA S45. Millipore. Bedford. MA. USA) were wetted with
PBS. coated with 50 ML per well of AFB-BSA. BSA. or TG
diluted to 20 |.ig/mL in PBS. and incubated overnight at room
temperature. Plates were then washed three times with PBS,
blotted dry with paper towels, and blocked with complete me-
dium for I h at room temperature. Complete medium (lOOpL)
containing 2 x lO*" viable cells/mL was added to each well and the
plates were incubated overnight (37.5°C. 5% CO^). LP lympho-
cytes were cultured at 1x10' ' viable cclls/mL. Plates were then
washed three times with phosphate butter (0.05 mol/L. pH 7.4}
containing 0,1'î i Tween 20 and 0.02'̂ ii sodium azide (PTA). Goat
anti-rabbit Ig (50 ^L per well, biotinylated m our laboratory-'').
diluted in PTA. was added and the plates were incubated over-
night at room temperature. Plates were washed three times with
PTA. and 50 pL of streptavidin-horseradish peroxidase (Amer-
sham. Arlington Heights. IL. USA) diluted in PTA was added to
eaeh well and ineubated for 1 h at room temperature. Plates were
washed three times with PTA and developed with 200 (iL per
well of the chromogen 3-amino-9-ethyIcarbazole (AEC. Sigma
A-6926) prepared aeeording to the manufacturer and filtered
through a 0,45 micron filter prior to use. After incubating for
several hours, the number of antibody seereting eells (ASC) was
scored using a dissecting microscope at 400 x magnification.
Enumeration of anti-AFB ASC was performed by subtraeting the
mean number of ASC in duplicate BSA-coated wells from the
mean number of ASC in duplicate AFB-BSA-eoated wells.
Anti-TG ASC were calculated by subtracting the mean ASC in
duplicate uneoated wells from the ASC in duplicate TG-coated
wells. ASC were converted to ASC per 10" expanded cells. Data
are expressed as the mcan±SEM of ASC from groups of three or
four animals.
Statistics
Data are expressed as the arithmetic mean ± SEM. The SAS (SAS
Institute. Cary, NC. USA) General Linear Models procedure was
used to compute analyses of variance. The LSMEANS option
within this procedure was used to analyse peak day differences
between the treatment groups. Student's /-test was used to deter-
mine differences between means of two groups. In all cases, a P
value of <0.05 was used as the threshold of significance.
Results
Mucosal unresponsiveness to AFB is not broken by CT
When AFB-TG conjugates mixed with CT were adminis-
tered to rabbits via isolated ileal loops, a minimal S-IgA
anti-AFB response was detected in ileal secretions assayed
at 4-day intervals (Fig. I). This response was barely de-
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Figure I Mueosal S-IgA anti-atlatoxin B, (AFB) response. Ani-
mals ( 'J-5) were primed with (•) 100)ig of aflatoxin B,-
thyroglobulin (AFB-TG) and (D) 100 ^g of AFB-TG + lOOfjgof
cholera toxin, via ehronically isolated ileal loops on day 0 and
given identical booster immunizations on days 7. 14 and 21. The
data points indicate the mean response (SEM). Intestinal seere-
tions at 4 day intervals were assayed by amplified ELISA at a
dilution of 1 : 8. Asterisks denote a signifieant ditference between
the groups (/*< 0.05).
substrate, and required the use of an amplified ELISA
protocol in order to quantify the response. Although sta-
tistically significant differences were noted at days 4 and
40. this response was not significantly different overall
from that of animals immunized with AFB-TG alone
{P = 0.\2\ Fig. I). demonstrating that CT did not act as an
adjuvant for AFB. The peak intestinal S-IgA anti-AFB
titre for this group was 8 (2\ Table 2). Mucosal immuni-
zation with AFB-BSA conjugates mixed with CT pro-
duced similar results (data not shown).
Mucosal unresponsiveness to AFB is hapten-speeific
In order to differentiate between hapten-specific unre-
sponsiveness and generalized immunosuppression. a
group of animals was mucosally immunized with uncon-
jugated TG mixed with CT (Table I. Group II). The intes-
tinal S-IgA anti-CT and anti-TG responses of these ani-
mals were comparable with those of animals immunized
with AFB-TG plus CT (Fig. 2). ruling out AFB-mediated
immunosuppression. Also, there were no significant dif-
ferences in the S-IgA anti-TG responses attributable to
conjugation with AFB (/'=0.33). The intestinal S-IgA
anti-TG response of animals immunized with AFB-TG
plus CT, or TG plus CT, was significantly greater than that
of animals immunized with AFB-TG or TG alone
(P = 0.0003). demonstratmg the adjuvancy of CT for the
anti-TG response (Fig. 2).
Animals immunized via ileal loop with AFB-TG
mixed with CT produced a small serum IgG anti-AFB
response, with an average titre of 16 (2**, Table 2). This
protocol did not generate measurable intestinal IgG or
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Table 2 Log base 2 peak titres (mean ± SEM) following m ucosal
and/or systemic immunization wiih aflatoxin B,-carrier protein
conjugates





















I 4 ±0 .4
III <3
V 15±O,7








































Group numbers arc as shown in Table I. The intestinal and
serum IgA and IgG anti-thyroglobulin and anti-cholera toxin
responses ofgroup 1 were not signifieantly different from those of
group II as measured by two-tailed Student's /-test {a = 0.0?). The
scrum IgG anti-thyroglobulin responses of groups V and VI were
not signifieantly different from each other or from that ofgroup
VIl by /-test, ND. experiment not done, NA. not applicable
(chronically isolated ileal loop surgery was not performed on
these animals),
ser^im IgA anti-AFB responses (Tahle 2). This immuniza-
tion protocol, however, generated high titre intestinal and
serum IgA and IgG responses to CT and TG which were
similar to those generated by mucosal immunization with
CT and unconjugated TG (Table 2).
Parenteral immunization generates high titre serum
IgG anti-AFB
To test whether the rabbits were capable of mounting a
systemic response to the AFB determinant, animals were
immunized i.m. with AFB-TG in CFA followed 4 weeks
later by a booster immunization with AFB-TG in IFA
(Table I. group VI). This immunization protocol gener-
ated high titre serum IgG anti-AFB and anti-TG re-
sponses which were comparable with those generated
by immunization with unconjugated TG in CFA/IFA
(Table I, group VII) (Table 2).
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FlKurt" 2 Mucosal S-IgA anti-cholera toxin (CT) and jnt i -
th\roglobuhn (TG) responses. .Animals were primed (a) \Mth
(D) IOOngCT+ 100 ^igofallatOMnB,-thyroglobulin (AFB-TG)
or ( 0 ) 100 ng T G + 100 pg of CT: and (b) with (D) 100 îg
CT+ 100|ig AFB-TG: m) 100 ̂ g of TG alone: m) 100 ^g
AFB-TG alone; or (EZl) l O O p g o f T G ^ 100 |ag of CT. via chron-
ieally isolated ileal loops, on day 0 as indicated, and given iden-
tical booster immunizations on days 7, 14 and 21. The data
points indicate the mean response (SEM), Intestinal secretions at
4-day intervals were assayed at a dilution of (a) 1 : 2 " or (b)
1 : 2 " ' and measured by amplitied ELISA: n^5 for AFB-TG
with CT. TG with CT. and AFB-TG groups: n ̂  2 for TG alone
group. Asterisks in panel (b) denote a significant ditterence
{P < 0.05) from the group imnuini/cd with AFB-TG mixed with
CT,
and an i,m. booster immunization with AFB-TG in IFA
on day 55 (Table 1, group V). This immunization protocol
generated high titre serum IgG responses to AFB and TG.
which were comparable with those generated b\ i.tii. im-
munization with AFB-TG in CFA-IF.-X without prior
immunization via ileal loop (Table 2).
Mucosal unresponsiveness is not accompanied by
systemic 'oral' tolerance
As the AFB determinant appeared to be refractorv' to the
adjuvancy of CT. it was of interest to know whether im-
munization with the conjugate preparation was associated
with a concomitant systemic tolerance ('oral tolerance') to
this determinant. A group of rabbits was immunized
weekly via ileal loops with AFB-TG plus CT followed by
an i.m. immunization with AFB-TG in CFA on day 25.
AFB-specific B cells reside in mucosal lymphoid ti.ssue
In order to determine whether the inability ofthe mucosal
arm of the immune system to mount an anti-AFB re-
sponse was caused by a lack of .AFB-specific B-celts in
mucosal lymphoid tissue, we stimulated lymphocytes
from LP, MLN, PP. and SP of unimmunized animals with
the mitogens LPS and PWM, This rnethod was chosen
because in vitto stimulation of PP and SP lymphocytes
from naive rabbits with AFB-TG proved unsuccessful
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(data not shown). TG-specific cells were found in MLN.
PP and SP at comparable levels (Table 3). AFB-specific
cells were also found in these tissues at levels comparable
with those of TG-specific cells (Table 3). No AFB-specific
or TG-specific cells were found in LP or in unstimulated
control cultures (data not shown).
Discussion
In previous studies from our laboratory and others, mu-
cosal immunization with carcinogen-carrier protein con-
jugates produced mucosal anti-carcinogen Ab responses
that bound to'^-^'^ and blocked transmucosal absorption
of the parent compound."* In preliminar\' studies, how-
ever, we obset^ed a marked mucosal hyporesponsiveness
to the dietary carcinogen AFB following immunization of
rabbits, via chronically isolated ilea! loops, with AFB-TG
conjugates mixed with CT. These animals had S-IgA
anti-CT and anti-TG titres comparable with those of ani-
mals immunized with CT and unconjugated TG. demon-
strating that CT acts as an adjuvant for TG but not for
AFB in the rabbit intestine and that unresponsiveness is
thus specific to the AFB determinant. Additionally, al-
though a small serum IgG anti-AFB response was gener-
ated by mucosal immunization with AFB-TG and CT,
this response vvas minimal in comparison with the serum
IgG anti-TG and anti-CT responses,
Parenteral immunization with AFB-TG in CFA/IFA
generated a strong serum IgG anti-AFB response that was
comparable in titre to the serum IgG anti-TG response.
Thus we infer that unresponsivess to AFB was restricted
to the mucosal arm ofthe immune system. These experi-
ments also demonstrate that the conjugate preparation
presented the AFB determinant in an immunogenic form
and that the rabbits possess the requisite systemic B and T
cell repertoires to mount an anti-AFB response. Further-
more, the serum IgG anti-AFB and anti-TG responses of
animals immunized mucosally with AFB-TG and CT
prior to systemic immunization with AFB-TG in CFA-
IFA were not significantly different from those of animals
immunized with AFB-TG or TG alone in CFA-IFA with-
out prior mucosal immunization. These observations
Tabled Spot forming cells to aflatoxin B, and thyroglobulin
from lymphoid organs of unimmunized animals
Organ
Peyer's patches {n = 4)
Spleen (n = 4)
Mesenteric lymph nodes
Peyer's patches (« - 4)













Data represent the number of antibody secreting cells (ASC)
per 10^ stimulated lymphocytes (mean±SE) after background
subtraction. The numbers of antibody secreting cells to aflatoxin
B, were not signiticantly different from those to thyroglubulin in
corresponding organs by Student's ^test.
demonstrate that mucosal unresponsiveness to AFB is not
accompanied by systemic tolerance and is thus a distinct
phenomenon from 'oral tolerance.' It is possible, however,
that CFA provides a stronger immunogenic signal than
CT and is thus able to overcome any systemic tolerance
that may have developed.
Mitogen stimulation of cells isolated from PP. SP and
MLN of unimmunized animals revealed the presence of
AFB- and TG-specific ASC at comparable levels in both
systemic and mucosal lymphoid tissues. Although this
method did not allow a quantitative estimate ofthe pre-
cursor frequency of AFB-spccifie B cells in these tissues, it
does demonstrate that B cells that were functionally aner-
gic //; vivo could be activated in vitro, in agreement with
the findings of Moller.-^
Although active suppression to AFB was not demon-
strated in these studies, the following lines of evidence
support the notion that unresponsiveness to AFB is main-
tained in the rabbit mucosa. First, AFB-specific B cells are
present in the mucosal lymphoid tissues, but do not re-
spond to antigen stimulation, even when the antigen is
co-administered with CT. This mucosal adjuvant can gen-
erate Ab responses to co-administered Ag that are as
much as 10- to 1 OOO-fold stronger than those generated by
Ag alone (Table 2,"̂  '*). Second, in previous studies. AAF-
carrier protein conjugates administered to rabbit ileal
loops at the same dose as was used in the present study
generated strong S-IgA anti-AAF responses.'*"*'''*
It is unclear how specific unresponsiveness to AFB is
established or maintained in the milieu ofa vigorous. Th2
dominated response to both CT and to TG, the latter of
which was covalently coupled to AFB. Our observations,
nonetheless, demonstrate that unresponsiveness to AFB is
hapten-specific. restricted to the mucosal immune system,
and refractory to the adjuvancy of CT.
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